Among Asian patients, the average incidences of EGFR mutations were 31% overall, 47% among patients with adenocarcinoma, and 56% among non-smokers; among other ethnic populations, however, the average incidences were 7–8% overall, 13–15% among patients with adenocarcinoma, and 34–35% among non-smokers (Table 3). The gene discussed is EGFR; the disease is adenocarcinoma.